Literature DB >> 17645645

Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension.

Dewan S A Majid1, Libor Kopkan.   

Abstract

1. Enhanced superoxide (O2(-)) activity as a result of the inhibition of the superoxide dismutase (SOD) enzyme results in vasoconstrictor and antinatriuretic responses in the canine kidney; these responses were shown to be greatly enhanced during inhibition of nitric oxide synthase (NOS). Glomerular filtration rate remained mostly unchanged during SOD inhibition in the intact nitric oxide (NO) condition, but was markedly reduced during NOS inhibition. These findings indicate that endogenous NO has a major renoprotective effect against O2(-) by acting as an anti-oxidant. Nitric oxide synthase inhibition was also shown to enhance endogenous O2(-) activity. 2. Experiments in our laboratory using dogs, rats and gene knockout mice have shown that renal vasoconstrictor and antinatriuretic responses to acute or chronic angiotensin (Ang) II administration are mediated, in part, by O2(-) generation. In the absence of NO, enhanced O2(-) activity largely contributes to AngII-induced renal tubular sodium reabsorption. Acute or chronic treatment with the O2(-) scavenger tempol in experimental models of hypertension (induced by chronic low-dose treatment with AngII and NO inhibitors) causes an improvement in renal haemodynamics and in excretory function, abolishes salt sensitivity and reduces blood pressure. 3. The present mini review also discusses related studies from many other laboratories implicating a role for O2(-) and its interaction with NO in the development of salt-sensitive hypertension. 4. Overall, the collective data support the hypothesis that an imbalance between the production of NO and O2(-) in the kidney primarily determines the condition of oxidative stress that alters renal haemodynamics and excretory function leading to sodium retention and, thus, contributes to the development of salt-sensitive hypertension.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17645645     DOI: 10.1111/j.1440-1681.2007.04642.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  39 in total

1.  The antihypertensive effect of arginine.

Authors:  Sudesh Vasdev; Vicki Gill
Journal:  Int J Angiol       Date:  2008

2.  Antihypertensive effects of dietary protein and its mechanism.

Authors:  Sudesh Vasdev; Jennifer Stuckless
Journal:  Int J Angiol       Date:  2010

3.  High-salt intake enhances superoxide activity in eNOS knockout mice leading to the development of salt sensitivity.

Authors:  Libor Kopkan; Arthur Hess; Zuzana Husková; Ludek Cervenka; L Gabriel Navar; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2010-07-07

Review 4.  Tumor necrosis factor-α, kidney function, and hypertension.

Authors:  Eamonn Mehaffey; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2017-07-19

Review 5.  Drug Treatment of Hypertension: Focus on Vascular Health.

Authors:  Alan C Cameron; Ninian N Lang; Rhian M Touyz
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

6.  Cholesterol induces renal vasoconstriction and anti-natriuresis by inhibiting nitric oxide production in anesthetized rats.

Authors:  Libor Kopkan; Md Abdul H Khan; Agnieszka Lis; Mouhamed S Awayda; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-23

7.  D5 dopamine receptor decreases NADPH oxidase, reactive oxygen species and blood pressure via heme oxygenase-1.

Authors:  Quansheng Lu; Yu Yang; Van Anthony Villar; Laureano Asico; John E Jones; Peiying Yu; Hewang Li; Edward J Weinman; Gilbert M Eisner; Pedro A Jose
Journal:  Hypertens Res       Date:  2013-02-21       Impact factor: 3.872

8.  Exogenous L-arginine ameliorates angiotensin II-induced hypertension and renal damage in rats.

Authors:  Niwanthi W Rajapakse; Carmen De Miguel; Satarupa Das; David L Mattson
Journal:  Hypertension       Date:  2008-11-03       Impact factor: 10.190

9.  Renal antioxidant enzymes and glutathione redox status in leptin-induced hypertension.

Authors:  Jerzy Bełtowski; Anna Jamroz-Wiśniewska; Grazyna Wójcicka; Ewelina Lowicka; Andrzej Wojtak
Journal:  Mol Cell Biochem       Date:  2008-08-09       Impact factor: 3.396

10.  Reduced renal responses to nitric oxide synthase inhibition in mice lacking the gene for gp91phox subunit of NAD(P)H oxidase.

Authors:  Mohammed Z Haque; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.